Page last updated: 2024-12-07

1-methylthymine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-methylthymine is a methylated derivative of thymine, a nucleobase found in DNA. It is an important component of DNA methylation, a critical epigenetic modification that influences gene expression and cellular processes. 1-methylthymine is formed by the methylation of the N1 position of thymine. This methylation is catalyzed by DNA methyltransferases (DNMTs). 1-methylthymine has been shown to play a role in various biological processes, including DNA replication, repair, and transcription. Studies have shown that 1-methylthymine can also be a biomarker for certain cancers and other diseases. The unique chemical structure and biological significance of 1-methylthymine make it a target for research and development in fields like cancer therapy, epigenetics, and diagnostics.'

1,5-dimethyluracil : A pyrimidone that is uracil with methyl group substituents at positions 1 and 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID95961
CHEMBL ID4586019
CHEBI ID74765
SCHEMBL ID12154069
SCHEMBL ID16248
MeSH IDM0096733

Synonyms (33)

Synonym
uracil, 1,5-dimethyl-
4160-72-9
1-methylthymine
1,5-dimethyluracil
nsc-44824
uracil,5-dimethyl-
nsc44824
2,3h)-pyrimidinedione, 1,5-dimethyl-
1,5-dimethylpyrimidine-2,4(1h,3h)-dione
1,5-dimethylpyrimidine-2,4-dione
AKOS004910261
SCHEMBL12154069
AKOS006238096
CHEBI:74765
unii-cn6a9brm5h
cn6a9brm5h ,
nsc 44824
2,4(1h,3h)-pyrimidinedione, 1,5-dimethyl-
1-methylh
FT-0635163
SCHEMBL16248
GKMIDMKPBOUSBQ-UHFFFAOYSA-N
W-202714
DTXSID30194426
Z821318488
Q27144889
4-hydroxy-1,5-dimethylpyrimidin-2(1h)-one
1,5-dimethyl-2,4(1h,3h)-pyrimidinedione
n1-methylthymine
AT19349
CHEMBL4586019
4-hydroxy-1,5-dimethyl-1,2-dihydropyrimidin-2-one
EN300-246064
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
methylthymineA pyrimidone that is thymine bearing a single methyl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (10.34)18.7374
1990's3 (10.34)18.2507
2000's11 (37.93)29.6817
2010's11 (37.93)24.3611
2020's1 (3.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.29 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.76 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]